Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Avandia (Rosiglitazone) Dosage

Share Post:

What is Rosiglitazone (Avandia)?

Rosiglitazone, also known by its brand name Avandia, is an oral diabetes drug that is used to control the level of blood glucose in patients with type 2 diabetes. Patients with type 2 diabetes experience high levels of blood sugar because their pancreas cannot produce enough insulin or they are resistant to insulin. Insulin is the natural hormone that helps glucose into the body cells for energy. Rosiglitazone belongs to a class of medication known as thiazolidinediones. Drugs in this class work by reducing the body’s resistance to insulin. This action helps to reduce high levels of blood sugar. Avandia can be combined with other diabetes drugs in patients with type 2 diabetes. This medication should not be used in patients with type 1 diabetes. Avandia works only if the beta cells can produce insulin normally. This medication is usually part of a treatment program that also includes diet and exercise.

Avandia Dosage

Your dosage of rosiglitazone will be based on response to the first dose, your age, and medical condition. The drug is available in dose strength of 4mg and 8mg. Usually the starting dose of this medicine is 4mg that should be taken orally once every day. If your level of blood sugar does not improve, your doctor may increase your dose. However, it should not exceed the maximum dosage of 8mg daily. This medication can be taken with meals or without. Make sure you take Avandia as your doctor prescribed it. Do not increase or reduce your dosage without your doctor’s knowledge.

You can order Rosiglitazone (Avandia) online and check prices at canadianinsulin.com


Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.
Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on April 22, 2021

Related Articles

Diabetes, Type 2
Semaglutide Shows Promise in Smoking Cessation for Patients with Type 2 Diabetes

Summary: Semaglutide shows promise in helping patients with type 2 diabetes quit smoking. A study found it reduced tobacco use disorder-related medical visits and the need for smoking cessation medications.…

Read More
Diabetes, Diabetes Supplies,
When Will Retatrutide Be Available? Insights into the Future of Diabetes and Obesity Care

Summary: Retatrutide is an innovative weight loss medication in Phase 3 trials, designed to target three key hormones to aid in weight loss and improve metabolic health. With its unique…

Read More
Diabetes, Diabetes Supplies,
How Does Retatrutide Work? A Deep Dive into Its Triple Receptor Action

Summary: Retatrutide, a groundbreaking multi-receptor agonist, targets GLP-1, GIP, and glucagon receptors to tackle obesity, type 2 diabetes, and metabolic disorders. Addressing multiple pathways offers comprehensive benefits in blood sugar…

Read More
Diabetes, Diabetes Supplies,
Navigating Retatrutide Side Effects: What to Expect During Treatment

Summary: Retatrutide is a promising new treatment for managing weight and metabolic disorders. However, understanding potential side effects is essential for safe use. This guide covers typical, moderate, and severe…

Read More